Page 153 - Pagetit
P. 153

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   excretion is increased, and smoking is decreased if nicotine is administered
                   concurrently either intravenously or with a patch. The genes involved in
                   nicotine metabolism may be important risk factors for smoking; the extent
                   of variation is likely to be a major determinant of levels and accumulation of
                   nicotine in the brain.
                     The metabolic enzyme CYP2A6 is genetically polymorphic (i.e. exists in
                   more than one form). It is responsible for about 90% of the metabolic
                   inactivation of nicotine to cotinine (Nakajima et al., 1996; Messina, Tyndale
                   & Sellers, 1997). A significant impact of CYP2A6 genetic variance has been
                   found on the risk for tobacco dependence, age of starting smoking, the
                   amount and patterns of cigarette smoking, duration of smoking, probability
                   of quitting, and some aspects of risk of developing lung cancer (Miyamoto et
                   al., 1999; Gu et al., 2000; Rao et al., 2000; Tyndale et al., 2002; Tyndale & Sellers,
                   2002). However, not all studies agree with these findings (Loriot et al., 2001;
                   Tiihonen et al., 2000; Zhang et al., 2001).
                     Among Caucasian smokers those with genetically slow nicotine metabolism
                   required fewer cigarettes per day, reflected in lower carbon monoxide levels,
                   to maintain equal plasma nicotine levels, while those with the CYP2A6 gene
                   duplication (fast metabolizers) smoked more, and with greater intensity (Rao
                   et al., 2000). In Caucasians, frequencies of genotypes with at least one decreased
                   or inactive allele were higher in non-smokers than in smokers (Tyndale et al.,
                   2002) indicating that slow nicotine inactivation modestly protects people from
                   becoming smokers. It has also been shown that inhibiting CYP2A6 (mimicking
                   the genetic defect) in smokers results in decreased smoking and rerouting of
                   procarcinogens to other detoxifying pathways (Sellers, Kaplan & Tyndale, 2000;
                   Sellers et al., 2002). Substantial variation in CYP2A6 allele and genotype
                   frequencies exists among ethnic groups (Oscarson et al., 1999; Tyndale et al.,
                   2002). These data suggest that the CYP2A6 genotype is likely to alter the risk for
                   smoking and may alter the risk for smoking-related disease (Bartsch et al., 2000)
                   among ethnic groups.


                   Genetics of alcohol dependence
                   Heritability of alcohol dependence

                   Heritability estimates of alcohol dependence depending on the diagnostic
                   criteria used (e.g. DSM-IV, ICD-10; see Boxes 1.2 and 1.3) range from 52% to
                   63% (van den Bree et al., 1998a). It seems that some diagnostic systems are
                   more sensitive in detecting genetic influences and may be more appropriate
                   for studies attempting to find genes for alcohol dependence (van den Bree et
                   al., 1998a).
                     Twin studies provide estimations of the heritability of predisposition to
                   alcohol dependence of 51–65% in females and 48–73% in males (Carmelli et
                   al., 1992; Kendler et al., 1994; Heath et al., 1997; Johnson et al., 1998; Han et
                   al., 1999a; Prescott, Aggen & Kendler, 1999; Prescott & Kendler, 1999; Enoch


                                                  132




          Chapter_5                132                             19.1.2004, 11:45
   148   149   150   151   152   153   154   155   156   157   158